Actively Recruiting
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-12-27
320
Participants Needed
1
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.
CONDITIONS
Official Title
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with advanced colorectal cancer confirmed by pathology or cytology and receiving first-line therapy
- Age 18 years or older, male or female
- ECOG performance status score between 0 and 2
- Expected survival of 3 months or more
- At least one measurable lesion according to RECIST 1.1 criteria
- Willing to participate voluntarily, sign informed consent, and comply with follow-up requirements
You will not qualify if you...
- Presence of other primary malignant tumors
- Patients with MSI-H/dMMR status based on immunohistochemistry, PCR, or sequencing
- Recurrence or metastasis within 6 months after radical tumor surgery
- Previous or ongoing cancer immunotherapy
- Patients currently receiving radiation therapy
- Pregnant or breastfeeding women; women of childbearing age and their partners must use effective contraception during and for 6 months after the study
- Psychiatric patients
- Severe, uncontrolled organic diseases or infections such as decompensated heart, lung, or kidney failure that prevent chemotherapy
- Participation in clinical trials of small molecule drugs within 28 days or large molecule drugs within 3 months
- Known allergy or intolerance to study drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, China
Actively Recruiting
Research Team
J
jie Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here